Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:20:25.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying who can answer questions about joining and providing information on the study's location, while removing the previous wording about those conducting the study.
    Difference
    3%
    Check dated 2024-12-07T19:24:15.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.
    Difference
    4%
    Check dated 2024-11-23T05:46:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    4%
    Check dated 2024-11-08T19:11:35.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:37:43.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.2%
    Check dated 2024-10-25T01:23:40.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.